skip to main content

Results 1 - 10 of 48  for Great Falls College MSU

Results 1 2 3 4 5 next page
Show only
Result Number Material Type Add to My Shelf Action Record Details and Options
1
EPA-0762 – Beyond depressive symptoms, how agomelatine modifies emotional reactivity, cognitive speed, motivation, psychomotor function and sensory perception?
Material Type:
Article
Add to e-Shelf

EPA-0762 – Beyond depressive symptoms, how agomelatine modifies emotional reactivity, cognitive speed, motivation, psychomotor function and sensory perception?

Gorwood, P. ; Vaiva, G. ; Corruble, E. ; Llorca, P.M. ; Bayle, F. ; Courtet, P.

European Psychiatry, 2014, Vol.29, S1, p.1 [Peer Reviewed Journal]

Full text available

View all versions
2
EPA-0601 – The increase of positive emotions after two weeks of agomelatine is more specific to predict later treatment response than the decrease of negative emotions.
Material Type:
Article
Add to e-Shelf

EPA-0601 – The increase of positive emotions after two weeks of agomelatine is more specific to predict later treatment response than the decrease of negative emotions.

Gorwood, P. ; Vaiva, G. ; Corruble, E. ; Llorca, P.M. ; Bayle, F. ; Courtet, P.

European Psychiatry, 2014, Vol.29, S1, p.1 [Peer Reviewed Journal]

Full text available

View all versions
3
EPA-1552 - Flexibly dosed paliperidone palmitate in non-acute but symptomatic patients with schizophrenia previously unsuccessfully treated with long-acting injectable risperidone
Material Type:
Article
Add to e-Shelf

EPA-1552 - Flexibly dosed paliperidone palmitate in non-acute but symptomatic patients with schizophrenia previously unsuccessfully treated with long-acting injectable risperidone

Schreiner, A. ; Bergmans, P. ; Llorca, P.M. ; Corrivetti, G. ; Cosar, B. ; Cherubin, P. ; Hargarter, L.

European Psychiatry, 2014, Vol.29, S1, p.1 [Peer Reviewed Journal]

Full text available

View all versions
4
EPA-1553 - Flexibly dosed paliperidone palmitate in non-acute patients with schizophrenia previously unsuccessfully treated with conventional depot antipsychotics
Material Type:
Article
Add to e-Shelf

EPA-1553 - Flexibly dosed paliperidone palmitate in non-acute patients with schizophrenia previously unsuccessfully treated with conventional depot antipsychotics

Schreiner, A. ; Hargarter, L. ; Llorca, P.M. ; Cosar, B. ; Petralia, A. ; Bergmans, P. ; Cherubin, P.

European Psychiatry, 2014, Vol.29, S1, p.1 [Peer Reviewed Journal]

Full text available

View all versions
5
EPA-0654 – Lack of inhibitory control predict relapse in people willing to stop smoking
Material Type:
Article
Add to e-Shelf

EPA-0654 – Lack of inhibitory control predict relapse in people willing to stop smoking

Flaudias, V. ; Lopez-Castroman, J. ; Llorca, P.M. ; Schmitt, A. ; Perriot, J. ; Picot, M. ; Courtet, P. ; Quantin, X. ; Guillaume, S.

European Psychiatry, 2014, Vol.29, S1, p.1 [Peer Reviewed Journal]

Full text available

View all versions
6
Material Type:
Article
Add to e-Shelf

Diagnostic criteria for apathy in clinical practice

Mulin, E ; Leone, E ; Dujardin, K ; Delliaux, M ; Leentjens, A ; Nobili, F ; Dessi, B ; Tible, O ; Agüera-Ortiz, L ; Osorio, R ; Yessavage, J ; Dachevsky, D ; Verhey, Frj ; Jentoft, Alfonso ; Blanc, O ; Llorca, Pm ; Robert, P

International Journal of Geriatric Psychiatry, Feb 2011, Vol.26(2), p.158 [Peer Reviewed Journal]

Full text available

View all versions
7
Material Type:
Article
Add to e-Shelf

Clinical potential of lurasidone in the management of schizophrenia

Samalin L ; Garnier M ; Llorca Pm

Therapeutics and Clinical Risk Management, 01 June 2011, Vol.2011(default), pp.239-250 [Peer Reviewed Journal]

Full text available

8
Outcomes In Schizophrenia: What Does “Clinically Meaningful” Mean To Payers?
Material Type:
Article
Add to e-Shelf

Outcomes In Schizophrenia: What Does “Clinically Meaningful” Mean To Payers?

Kilburg, A. ; Galani Berardo, C. ; Souto, D. ; Llorca, P.M.

Value in Health, 05/2014, Vol.17(3), p.A57 [Peer Reviewed Journal]

Full text available

9
Material Type:
Article
Add to e-Shelf

HRQOL IN NEGATIVE SYMPTOMS OF SCHIZOPHRENIA

Azaiez, C ; Llorca, Pm ; Lancon, C ; Auquier, P ; Millier, A ; Toumi, M

Value in Health : The Journal of the International Society for Pharmacoeconomics and Outcomes Research, May 2017, Vol.20(5), p.A300 [Peer Reviewed Journal]

Full text available

10
Relative Efficacy and Acceptability of Vortioxetine Versus Marketed Antidepressants
Material Type:
Article
Add to e-Shelf

Relative Efficacy and Acceptability of Vortioxetine Versus Marketed Antidepressants

Llorca, P.M. ; Lançon, C. ; Brignone, M. ; Rive, B. ; Salah, S. ; François, C.

Value in Health, 11/2013, Vol.16(7), p.A543 [Peer Reviewed Journal]

Full text available

View all versions

Results 1 - 10 of 48  for Great Falls College MSU

Results 1 2 3 4 5 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Show only

  1. Peer-reviewed Journals (26)

Refine My Results

Resource Type 

  1. Articles  (27)
  2. Text Resources  (15)
  3. More options open sub menu

Creation Date 

From To
  1. Before 2003  (4)
  2. 2003 To 2007  (3)
  3. 2008 To 2010  (10)
  4. 2011 To 2014  (14)
  5. After 2014  (17)
  6. More options open sub menu

Language 

  1. English  (27)
  2. French  (1)
  3. More options open sub menu

Searching Remote Databases, Please Wait